Weight-loss drug developer Metsera raises $275 million in US IPO-March 2024-www.financetom.com

Weight-loss drug developer Metsera raises $275 million in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Weight-loss drug developer Metsera raises $275 million in US IPO

Jan 30, 2025 4:35 PM

Jan 30 (Reuters) - Weight-loss drug developer Metsera

has raised $275 million after pricing its U.S. initial public

offering at $18 per share, above its targeted range, the ARCH

Venture Partners-backed biotech company said on Thursday.

Previous page： Shapoorji Pallonji Group may pledge shares in Tata Sons to raise $1.6 billion Next page： State Government infra spending yet to pick up to its true potential: Siemens

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Shapoorji Pallonji Group may pledge shares in Tata Sons to raise $1.6 billion

May 16, 2023

Bloomberg said that Deutsche Bank AG and Standard Chartered Plc are organising the private credit deal. Ontario Municipal Employees Retirement System, Varde Partners LP, Cerberus Capital Management LP and Farallon Capital Management LLC are also part of the discussions.

State Government infra spending yet to pick up to its true potential: Siemens

May 16, 2023

Though commodity prices are easing, margins are not expected to sustain in the 12 to 13 percent range in the long term as the revenue mix will keep changing.

PVR-Inox focus on penetrating further in South India markets

May 16, 2023

PVR-Inox which declared its results for the first time as a merged entity on Monday post market hours, reported 34...

Newsletter | Shilpa Shetty invests in WickedGud; Amazon sacks 500 workers in India; Active vs passive MFs & more

May 16, 2023

Here's a rundown of 11 significant news stories to keep you in the know: Share Market Live NSE #MostRead⚡ Shilpa...